Notes

all the demographic data was as expected and was comparable to the UK averages. In terms of the anaesthetic and surgical times they were similar to the previous audit’s results, whereas the length of stay had reduced and was considerably shorter than that of other studies. The primary anaesthetic data was also as expected; however, the method of LA administration was not documented often enough and needs to be addressed in the action plan. The proportion of use of intraoperative analgesics had only minimally changed, with the exception of the increased use of oxycodone which could be due to its more favourable pharmacological properties with regards to patients with ESRD. The muscle relaxant results showed that cisatracurium was most commonly used due to its pharmacokinetic advantages in renal patients as well as its low potential for anaphylaxis. Neostigmine was the reversal agent that was employed the most but sugammadex was starting to become a potential alternative. Desflurane was more popular than sevoflurane and this was the same in the previous audit. The type of fluid were